Alterations in oxidative stress biomarkers associated with mild hyperlipidemia and smoking

Food and Chemical Toxicology

Volumn 50, Issue 3-4, 2012, Pages 920-926

  Miri, Ramin ^a   Saadati, Hamideh ^b   Ardi, Pegah ^a   Firuzi, Omidreza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Saadati Pathobiology Laboratory   (Iran)

Author keywords

Cigarette smoking; Hypercholesterolemia; Hyperlipidemia; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; CATALASE; CHOLESTEROL; GLUCOSE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BIOASSAY; COMBINED HYPERLIPIDEMIA; CONTROLLED STUDY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENZYME ACTIVITY; ERYTHROCYTE METABOLISM; FERRIC REDUCING ANTIOXIDANT POWER ASSAY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LEUKOCYTE COUNT; MALE; OXIDATIVE STRESS; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CATALASE; DINOPROST; GLUTATHIONE PEROXIDASE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SMOKING; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84856480527     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.12.031     Document Type: Article

References (46)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Anderson K.M., Castelli W.P., Levy D. Cholesterol and mortality. 30years of follow-up from the Framingham study. JAMA 1987, 257:2176-2180.
3. Bartecchi C.E., MacKenzie T.D., Schrier R.W. The human costs of tobacco use (1). N. Engl. J. Med. 1994, 330:907-912.
4. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
5. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of <>: the FRAP assay. Anal. Biochem. 1996, 239:70-76.
6. Burke A., Fitzgerald G.A. Oxidative stress and smoking-induced vascular injury. Prog. Cardiovasc. Dis. 2003, 46:79-90.
7. Cardona F., Tunez I., Tasset I., Murri M., Tinahones F.J. Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome. Clin. Biochem. 2008, 41:701-705.
8. Chehne F., Oguogho A., Lupattelli G., Budinsky A.C., Palumbo B., Sinzinger H. Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking. Prostaglandins Leukot. Essent. Fatty Acids 2001, 64:307-310.
9. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 2000, 86:943-949.
10. de Man F.H., Jonkers I.J., Schwedhelm E., Smelt A.H., Onkenhout W., van Duyvenvoorde W., Buytenhek R., Leuven J.A., Troost R., van Der Laarse A., Princen H.M. Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2434-2440.
11. Dillon S.A., Lowe G.M., Billington D., Rahman K. Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F(2 alpha) in smoking and nonsmoking men and women. J. Nutr. 2002, 132:168-171.
12. Duarte M.M., Moresco R.N., Duarte T., Santi A., Bagatini M.D., Da Cruz I.B., Schetinger M.R., Loro V.L. Oxidative stress in hypercholesterolemia and its association with Ala16Val superoxide dismutase gene polymorphism. Clin. Biochem. 2010, 43:1118-1123.
13. Firuzi O., Fuksa L., Spadaro C., Bousova I., Riccieri V., Spadaro A., Petrucci R., Marrosu G., Saso L. Oxidative stress parameters in different systemic rheumatic diseases. J. Pharm. Pharmacol. 2006, 58:951-957.
14. Firuzi O., Mladenka P., Riccieri V., Spadaro A., Petrucci R., Marrosu G., Saso L. Parameters of oxidative stress status in healthy subjects: their correlations and stability after sample collection. J. Clin. Lab. Anal. 2006, 20:139-148.
15. Firuzi O., Spadaro A., Spadaro C., Riccieri V., Petrucci R., Marrosu G., Saso L. Protein oxidation markers in the serum and synovial fluid of psoriatic arthritis patients. J. Clin. Lab. Anal. 2008, 22:210-215.
16. Garg N., Singh R., Dixit J., Jain A., Tewari V. Levels of lipid peroxides and antioxidants in smokers and nonsmokers. J. Periodontal Res. 2006, 41:405-410.
17. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, USA. 4 ed.
18. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 2003, 91:7A-11A.
19. Heitzer T., Yla-Herttuala S., Luoma J., Kurz S., Munzel T., Just H., Olschewski M., Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996, 93:1346-1353.
20. Helmersson J., Larsson A., Vessby B., Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005, 181:201-207.
21. Jha J.C., Maharjan B.R., Adhikari D., Vishwanath P., Akila Nagamma T., Azhari S., Singh P.P. Cigarette smoke induced oxidative insult in local population of Pokhara. Kathmandu Univ. Med. J. (KUMJ) 2007, 5:511-517.
22. Kitano S., Hisatomi H., Hibi N., Kawano K., Harada S. Improved method of plasma 8-isoprostane measurement and association analyses with habitual drinking and smoking. World J. Gastroenterol. 2006, 12:5846-5852.
23. Kotani K., Koibuchi H., Miyamoto M., Yamada T., Taniguchi N. Relationship between reactive oxygen metabolites and carotid intima-media thickness in subjects with hypercholesterolemia. Med. Princ. Pract. 2010, 19:496-498.
24. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin. Chim. Acta 2007, 380:50-58.
25. Maas R., Schwedhelm E., Kahl L., Li H., Benndorf R., Luneburg N., Forstermann U., Boger R.H. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. Clin. Chem. 2008, 54:292-300.
26. Martinez-Hervas S., Fandos M., Real J.T., Espinosa O., Chaves F.J., Saez G.T., Salvador A., Cerda C., Carmena R., Ascaso J.F. Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis 2008, 199:384-389.
27. Morrow J.D., Frei B., Longmire A.W., Gaziano J.M., Lynch S.M., Shyr Y., Strauss W.E., Oates J.A., Roberts L.J. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers in Smoking as a cause of oxidative damage. N. Engl. J. Med. 1995, 332:1198-1203.
28. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 1990, 87:9383-9387.
29. Munzel T., Gori T., Bruno R.M., Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease?. Eur. Heart J. 2010, 31:2741-2748.
30. Mur C., Claria J., Rodela S., Lario S., Campistol J.M., Titos E., Inigo P., Cases A., Abian J., Esmatjes E. Cigarette smoke concentrate increases 8-epi-PGF2alpha and TGFbeta1 secretion in rat mesangial cells. Life Sci. 2004, 75:611-621.
31. NCEP Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
32. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:759-767.
33. Ohashi N., Yoshikawa M. Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 2000, 746:17-24.
34. Padmavathi P., Damodara Reddy V., Narendra M., Varadacharyulu N. Bidis - Hand-rolled, Indian cigarettes: induced biochemical changes in plasma and red cell membranes of human male volunteers. Clin. Biochem. 2009, 42:1041-1045.
35. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
36. Park E.M., Ramnath N., Yang G.Y., Ahn J.Y., Park Y., Lee T.Y., Shin H.S., Yu J., Ip C., Park Y.M. High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis. Free Radic. Biol. Med. 2007, 42:280-287.
37. Pignatelli B., Li C.Q., Boffetta P., Chen Q., Ahrens W., Nyberg F., Mukeria A., Bruske-Hohlfeld I., Fortes C., Constantinescu V., Ischiropoulos H., Ohshima H. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res. 2001, 61:778-784.
38. Pirinccioglu A.G., Gokalp D., Pirinccioglu M., Kizil G., Kizil M. Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clin. Biochem. 2010, 43:1220-1224.
39. Pronai L., Hiramatsu K., Saigusa Y., Nakazawa H. Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis 1991, 90:39-47.
40. Puri B.K., Treasaden I.H., Cocchi M., Tsaluchidu S., Tonello L., Ross B.M. A comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation. BMC Psychiatry 2008, 8(Suppl. 1):S4.
41. Real J.T., Martinez-Hervas S., Tormos M.C., Domenech E., Pallardo F.V., Saez-Tormo G., Redon J., Carmena R., Chaves F.J., Ascaso J.F., Garcia-Garcia A.B. Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia. Metabolism 2010, 59:293-298.
42. Reilly M.P., Pratico D., Delanty N., DiMinno G., Tremoli E., Rader D., Kapoor S., Rokach J., Lawson J., FitzGerald G.A. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation 1998, 98:2822-2828.
43. Shanely R.A., Nieman D.C., Henson D.A., Jin F., Knab A.M., Sha W. Inflammation and oxidative stress are lower in physically fit and active adults. Scand. J. Med. Sci. Sports 2011.
44. Sun Y.I., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497.
45. Yamaguchi Y., Haginaka J., Morimoto S., Fujioka Y., Kunitomo M. Facilitated nitration and oxidation of LDL in cigarette smokers. Eur. J. Clin. Invest. 2005, 35:186-193.
46. Yang R.L., Shi Y.H., Hao G., Li W., Le G.W. Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J. Clin. Biochem. Nutr. 2008, 43:154-158.